These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16054240)

  • 1. Regulation of vascular reactivity by established and emerging GPCRs.
    Maguire JJ; Davenport AP
    Trends Pharmacol Sci; 2005 Sep; 26(9):448-54. PubMed ID: 16054240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovering orphan receptor function using human in vitro pharmacology.
    Maguire JJ
    Curr Opin Pharmacol; 2003 Apr; 3(2):135-9. PubMed ID: 12681234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.
    Behm DJ; Harrison SM; Ao Z; Maniscalco K; Pickering SJ; Grau EV; Woods TN; Coatney RW; Doe CP; Willette RN; Johns DG; Douglas SA
    Br J Pharmacol; 2003 May; 139(2):464-72. PubMed ID: 12770952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system.
    Katugampola SD; Maguire JJ; Kuc RE; Wiley KE; Davenport AP
    Can J Physiol Pharmacol; 2002 May; 80(5):369-74. PubMed ID: 12056541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orphan GPCRs and methods for identifying their ligands.
    Yoshida M; Miyazato M; Kangawa K
    Methods Enzymol; 2012; 514():33-44. PubMed ID: 22975044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of novel G-protein-coupled receptors and their ligands in the cardiovascular system].
    Földes G; Tóth M
    Orv Hetil; 2004 Mar; 145(11):561-6. PubMed ID: 15098504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1.
    Wiley KE; Davenport AP
    Br J Pharmacol; 2002 Aug; 136(8):1146-52. PubMed ID: 12163347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orphan G protein-coupled receptors and obesity.
    Xu YL; Jackson VR; Civelli O
    Eur J Pharmacol; 2004 Oct; 500(1-3):243-53. PubMed ID: 15464037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system.
    Katugampola S; Davenport A
    Trends Pharmacol Sci; 2003 Jan; 24(1):30-5. PubMed ID: 12498728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
    Hoyer D; Bartfai T
    Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors.
    Katugampola SD; Kuc RE; Maguire JJ; Davenport AP
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():171S-175S. PubMed ID: 12193079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the gastroprokinetic effects of ghrelin, GHRP-6 and motilin in rats in vivo and in vitro.
    Depoortere I; De Winter B; Thijs T; De Man J; Pelckmans P; Peeters T
    Eur J Pharmacol; 2005 May; 515(1-3):160-8. PubMed ID: 15890336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of urotensin II on vascular tone in normal subjects and patients with chronic heart failure.
    Lim M; Honisett S; Sparkes CD; Komesaroff P; Kompa A; Krum H
    Circulation; 2004 Mar; 109(10):1212-4. PubMed ID: 15007012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
    Ames RS; Sarau HM; Chambers JK; Willette RN; Aiyar NV; Romanic AM; Louden CS; Foley JJ; Sauermelch CF; Coatney RW; Ao Z; Disa J; Holmes SD; Stadel JM; Martin JD; Liu WS; Glover GI; Wilson S; McNulty DE; Ellis CE; Elshourbagy NA; Shabon U; Trill JJ; Hay DW; Ohlstein EH; Bergsma DJ; Douglas SA
    Nature; 1999 Sep; 401(6750):282-6. PubMed ID: 10499587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urotensin II: its function in health and its role in disease.
    Ong KL; Lam KS; Cheung BM
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):65-75. PubMed ID: 15883758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between human urotensin II and vasodilator agents in human internal mammary artery with possible clinical implications.
    Bai XY; Liu XC; Yang Q; Tang XD; He GW
    Ann Thorac Surg; 2011 Aug; 92(2):610-6. PubMed ID: 21704284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide ligands that target peptide-activated GPCRs in inflammation.
    Blakeney JS; Fairlie DP
    Curr Med Chem; 2005; 12(25):3027-42. PubMed ID: 16378503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.
    Chapter MC; White CM; DeRidder A; Chadwick W; Martin B; Maudsley S
    Pharmacol Ther; 2010 Jan; 125(1):39-54. PubMed ID: 19686775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?
    Giachini FR; Callera GE; Carneiro FS; Tostes RC; Webb RC
    Expert Opin Ther Targets; 2008 Mar; 12(3):327-39. PubMed ID: 18269342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urotensin-II, a neuropeptide ligand for GPR14, induces c-fos in the rat brain.
    Gartlon JE; Ashmeade T; Duxon M; Hagan JJ; Jones DN
    Eur J Pharmacol; 2004 Jun; 493(1-3):95-8. PubMed ID: 15189768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.